M
Metagenomi Therapeutics, Inc. (MGX)
NMS – Real Time Price. Currency in USD
1.25
+0.06 (5.04%)
At close: Jun 26, 2026, 4:00 PM EDT
1.25
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
1.25
+0.06 (5.04%)
At close: Jun 26, 2026, 4:00 PM EDT
1.25
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
Total debt $39.2M significantly exceeds cash reserves ($25.3M), raising financial stability concerns
Total current assets $144.6M exceed Total current liabilities $22.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.3) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$21.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.43 | 6.05 | 10 | |
| Quick ratio | 6.43 | 5.63 | 10 | |
| Debt to Equity | 0.28 | 0.30 | 8.0 | |
| Debt to Assets | 0.20 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 17M | 45M | 52M | 25M | 22M |
| Gross Profit | 15M | 41M | 47M | 20M | 17M |
| Operating Income | -45M | -78M | -89M | -96M | -93M |
| Net Income | -44M | -68M | -78M | -88M | -86M |
| EBITDA | -43M | -74M | -83M | -91M | -88M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -60.51 | -6.73 | 1.0 |
| Next quarter | -61.17 | -3.25 | 1.0 |
| Current year | -51.81 | 10.01 | 4.0 |
| Next year | 3.09 | 26.3 | 7.0 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -68.08 | -2.35 | -3.38 | 10.29 | 2.5 |
| Y/Y | -69.75 | 7.91 | 10.29 | 8.34 | 5.0 |
| 3y average | 41.76 | -27.81 | 44.12 | -244.45 | 5.5 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 3.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |